Watchlist Price Alert

Tekla Life Sciences Inves... (HQL)

NYSE: HQL · Real-Time Price · USD

12.96

0.16 (1.25%)

At close: Jun 10, 2025, 3:59 PM

12.72

-1.89%

After-hours: Jun 10, 2025, 07:26 PM EDT

Tekla Life Sciences Investors Cash Flow Statement

Financials in USD. Fiscal year is October - September.

Fiscal Year	Q4 2024	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018	Q4 2017	Q2 2017	Q4 2016	Q2 2016
Period Ending	Sep 30, 2024	Mar 30, 2024	Sep 30, 2023	Mar 31, 2023	Sep 30, 2022	Mar 30, 2022	Sep 30, 2021	Mar 30, 2021	Sep 30, 2020	Mar 30, 2020	Sep 30, 2019	Mar 30, 2019	Sep 30, 2018	Mar 30, 2018	Sep 30, 2017	Mar 30, 2017	Sep 30, 2016	Mar 30, 2016
Net Income	n/a	11.18M	44.98M	33.75M	-104.6K	-20.04K	64.53K	93.79K	123.05K	26.29K	-70.48K	-20.91K	28.66K	48.61K	68.56K	28.32K	-11.91K	85.1K
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Working Capital	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	417.05
Other Non-Cash Items	n/a	-11.18M	-44.98M	-33.75M	104.6K	20.04K	-64.53K	-93.79K	-123.05K	-26.29K	70.48K	20.91K	-28.66K	-48.61K	-68.56K	-28.32K	11.91K	-39.69K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	400.79
Operating Cash Flow	n/a	n/a	n/a	n/a	n/a	-0.37	-0.74	-0.37	n/a	-0.31	-0.62	-0.31	n/a	n/a	n/a	n/a	n/a	45.81K
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-10.07K
Other Financial Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Financial Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-10.07K
Net Cash Flow	n/a	32.00	32.00	-545	-1.09K	-545.74	-1.49	-0.74	n/a	1.12M	2.25M	1.12M	n/a	n/a	n/a	n/a	n/a	17.87K
Free Cash Flow	n/a	n/a	n/a	n/a	n/a	-0.37	-0.74	-0.37	n/a	-0.31	-0.62	-0.31	n/a	n/a	n/a	n/a	n/a	45.81K